Targeted HIV drug resistance testing moves into routine care in South Africa

Researchers at Wits University, South Africa's National Health Laboratory Service (NHLS) and University Medical Center Utrecht have developed a new way to help people whose HIV viral load increased while they were taking the highly effective standard antiretroviral treatment dolutegravir (DTG).

Read it at Medical Xpress ↗

← Front page